About Index Trending news
Analyze
Pricing
AntriaBio

AntriaBio

Work at AntriaBio? Add yourself to this profile

AntriaBio

AntriaBio is developing proprietary products in sustained release injectable formulations including AB101, a once-a-week basal insulin. $ANTB

Elsewhere

Alexa global traffic share

Twitter followers

21 Mar 2016
$4,350,000
Venture capital (Series A)

SEC FORM D

sec
+1
16 Apr 2015
$2,000,000
Venture capital
14 Apr 2014
$7,296,453
Venture capital
14 Jan 2014
$1,420,000
Debt financing
14 Jan 2013
$825,000
Debt financing
16 Aug 2012
$1,825,000
Debt financing